1: KONDO S. [SARKOMYCIN AS OF DECEMBER 1961]. J Antibiot B. 1963 Jun;16:210-9. Japanese. PMID: 14043983.
2: ISHIYAMA S. [Sarkomycin]. Gan. 1956 Dec;47(3-4):444-5. Japanese. PMID: 13415076.
3: UMEZAWA H, YAMAMOTO T, TAKEUCHI T, OSATO T, OKAMI Y, YAMAOKA S, OKUDA T, NITTA K, YAGISHITA K, UTAHARA R, UMEZAWA S. Sarkomycin, and anti-cancer substance produced by Stroptomyces. Antibiot Chemother (Northfield). 1954 May;4(5):514-20. PMID: 24543024.
4: Hill RK, Foley PJ Jr, Gardella LA. The absolute configuration of sarkomycin. J Org Chem. 1967 Jul;32(7):2330-5. doi: 10.1021/jo01282a052. PMID: 6046180.
5: TOKI K, WADA H, SUZUKI Y, SAITO C. Synthesis of sarkomycin. J Antibiot (Tokyo). 1957 Jan;10(1):35. PMID: 13449006.
6: Liu LF, Qi H, Zhang H, Wang JD, Yu NF. A new sarkomycin analog from Streptomyces sp. HS-HY-144. J Antibiot (Tokyo). 2015 Dec;68(12):760-2. doi: 10.1038/ja.2015.66. Epub 2015 Jun 10. PMID: 26058568.
7: KEIR HM, SHEPHERD JB. THIOL GROUPS IN DEOXYRIBONUCLEIC ACID NUCLEOTIDYLTRANSFERASE. Biochem J. 1965 May;95(2):483-9. doi: 10.1042/bj0950483. PMID: 14340098; PMCID: PMC1214347.
8: HOOPER IR, CHENEY LC, CRON MJ, FARDIG OB, JOHNSON DA, JOHNSON DL, PALERMITI FM, SCHMITZ H, WHEATLE WB. Studies on sarkomycin. Antibiot Chemother (Northfield). 1955 Oct;5(10):585-95. PMID: 24543775.
9: Westmeier J, Kress S, Pfaff C, von Zezschwitz P. Total synthesis of (R)-sarkomycin via asymmetric rhodium-catalyzed conjugate addition. J Org Chem. 2013 Nov 1;78(21):10718-23. doi: 10.1021/jo4016979. Epub 2013 Oct 14. PMID: 24079484.
10: Cabré A, Khaizourane H, Garçon M, Verdaguer X, Riera A. Total Synthesis of ( R)-Sarkomycin Methyl Ester via Regioselective Intermolecular Pauson-Khand Reaction and Iridium-Catalyzed Asymmetric Isomerization. Org Lett. 2018 Jul 6;20(13):3953-3957. doi: 10.1021/acs.orglett.8b01525. Epub 2018 Jun 15. PMID: 29905075.
11: AKITA E, HARA T, YAMADA Y. Studies on sarkomycin. VII. Effects of sarkomycin and related compounds on the anaerobic fermentation of Ehrlich ascites carcinoma cells of mice. J Antibiot (Tokyo). 1956 Sep;9(5):191-2. PMID: 13385197.
12: ISHIYAMA S, ISHIYAMA I, SAKURAI H, FUJII R, SHIRASUGA Y. Concentration of sarkomycin in the body fluid and its urinary excretion, preliminary report. J Antibiot (Tokyo). 1955 Jan;8(1):22-5. PMID: 14367229.
13: TANAKADATE Y, HASEGAWA S, OHASHI I, SAKAI F, NAKASEKO H. [Cytostatic effect of antibiotics (actinomycin J, sarkomycin and pluramycin) on Yoshida ascites sarcoma cells]. Gan. 1956 Dec;47(3-4):357-8. Japanese. PMID: 13415038.
14: Hatano M, Sakamoto T, Mizuno T, Goto Y, Ishihara K. Chiral Supramolecular U-Shaped Catalysts Induce the Multiselective Diels-Alder Reaction of Propargyl Aldehyde. J Am Chem Soc. 2018 Nov 28;140(47):16253-16263. doi: 10.1021/jacs.8b09974. Epub 2018 Nov 15. PMID: 30404439.
15: UMEZAWA H, TAKEUCHI T, NITTA K, YAMAMOTO T, YAMAOKA S. Sarkomycin, an anti- tumor substance produced by streptomyces. J Antibiot (Tokyo). 1953 Apr;6(2):101. PMID: 13084510.
16: Rebroš M, Lipták L, Rosenberg M, Bučko M, Gemeiner P. Biocatalysis with Escherichia coli-overexpressing cyclopentanone monooxygenase immobilized in polyvinyl alcohol gel. Lett Appl Microbiol. 2014 Jun;58(6):556-63. doi: 10.1111/lam.12227. Epub 2014 Feb 24. PMID: 24494800.
17: Kondo S, Nakamura H, Ikeda Y, Naganawa H, Maeda K, Takeuchi T. Structures of two remarkable dimerization products of sarkomycin. J Antibiot (Tokyo). 1997 Apr;50(4):363-5. doi: 10.7164/antibiotics.50.363. PMID: 9186566.
18: Königsberger K, Griengl H. Microbial Baeyer-Villiger reaction of bicyclo[3.2.0]heptan-6-ones--a novel approach to sarkomycin A. Bioorg Med Chem. 1994 Jul;2(7):595-604. doi: 10.1016/0968-0896(94)85006-2. PMID: 7858964.
19: TAKEUCHI T, HIKIJI T, NITTA K, MORIKUBO Y, UMEZAWA H. On antitumor effect of sarkomycin-INH. J Antibiot (Tokyo). 1958 Sep;11(9):212-6. PMID: 13610779.
20: Koenuma M, Kinashi H, Otake N. An improved screening method for antiphage antibiotics and isolation of sarkomycin and its relatives. J Antibiot (Tokyo). 1974 Oct;27(10):801-4. doi: 10.7164/antibiotics.27.801. PMID: 4457528.